GUFIC AVICENNA JOINT VENTURE
Company Profile:
Gufic Avicenna Joint Venture
Type: Factory (Manufacturer)
Introduction:
Gufic Avicenna Joint Venture is a pharmaceutical manufacturing company based in Uzbekistan. It was established as a strategic collaboration between Gufic Biosciences Limited, a well-known Indian pharmaceutical company, and Avicenna LLC, an Uzbek entity. The joint venture operates a modern manufacturing facility dedicated to producing a diverse portfolio of pharmaceutical formulations, including injectables, tablets, and capsules. Its core mission is to provide high-quality, accessible, and affordable medicines to meet the healthcare needs of the Uzbek population and to serve the wider Central Asian market, thereby strengthening regional pharmaceutical production capabilities.
Enterprise Products
Gufic Avicenna Joint Venture, located in Uzbekistan, manufactures and sells a range of pharmaceutical products. These products typically include various pharmaceutical formulations across different therapeutic categories.
The primary product forms manufactured and sold are:
Tablets
Capsules
Oral liquid preparations such as syrups and suspensions
Injectable formulations, including ampoules and vials
Topical preparations like creams and ointments
The therapeutic areas covered by their product portfolio commonly include:
Anti-infective agents, such as antibiotics and antifungals
Analgesics and anti-inflammatory drugs for pain and inflammation management
Vitamins and nutritional supplements
Cardiovascular medications for heart and circulatory conditions
Gastrointestinal medications for digestive health
Respiratory medications for lung and airway conditions
Business Registration Information:
Manager:
P.C. Jain (General Manager)
Phone:
+998 71 262 76 66, +998 71 262 76 67
E-mail:
Official Website:
Address:
28, Buyuk Ipak Yuli Street, Tashkent, Uzbekistan
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.